Biomolecular Research on Electroconvulsive Therapy for Mental Disorders: State of the Art and Future Directions

Affiliations

Editorial

Daniele Cavaleri et al. Alpha Psychiatry. 2022.

. 2022 Mar 1;23(2):57-58.

doi: 10.5152/alphapsychiatry.2022.0003. eCollection 2022 Mar.

¹ Department of Medicine and Surgery, University of Milano-Bicocca, Milano, Italy.

No abstract available

References

1. Kellner CH, Obbels J, Sienaert P. When to consider electroconvulsive therapy (ECT). Acta Psychiatr Scand. 2020;141(4):304–315.. 10.1111/acps.13134) - DOI - PubMed
1. Guloksuz S, Rutten BP, Arts B, van Os J, Kenis G. The immune system and electroconvulsive therapy for depression. J ECT. 2014;30(2):132–137.. 10.1097/YCT.0000000000000127) - DOI - PubMed
1. Atagün Mİ, Canbek ÖA. A systematic review of the literature regarding the relationship between oxidative stress and electroconvulsive therapy. Alpha Psychiatry. 2021. 10.5152/alphapsychiatry.2021.21584) - DOI - PMC - PubMed
1. van Buel EM, Patas K, Peters M, Bosker FJ, Eisel UL, Klein HC. Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all? Transl Psychiatry. 2015;5(7):e609. 10.1038/tp.2015.100) - DOI - PMC - PubMed
1. van Zutphen EM, Rhebergen D, van Exel E.et al. Brain-derived neurotrophic factor as a possible predictor of electroconvulsive therapy outcome. Transl Psychiatry. 2019;9(1):155. 10.1038/s41398-019-0491-9) - DOI - PMC - PubMed